We did a thing! pubs.rsc.org/ob/article/doi/…
This review, which is part of a themed collection on axially chirality, was written with the goal of sharing some fundamentals and capturing a 'snapshot' of the state of atropisomerism in drug discovery.
One thing worth mentioning is the majority of examples utilized tried and true chiral resolution chemistry, however there was a lot of innovation in recycling of the unwanted atropisomer. There were also a few examples of asymmetric catalysis being employed.
Excited to announce that the preliminary program for the 2027 Gordon Research Conference on Heterocyclic Compounds, June 20–25 in Newport, RI, is online!
grc.org/heterocyclic-compoun…
We have an outstanding lineup of academic and industry scientists. Hope to see many of you there!
You forgot to mention the PhD's beat the PhD Candidates in volleyball
a successful beach day (most) of the organic chemistry groups along with a PhDs vs Candidates volleyball match! (a few injuries, no deaths) @GustafsonLab @jillalty @barneygrubbs @QJBruch Prof. Katherine Aubrecht and Prof. Matthew Parkers Group
Another day another preprint on ChemRxiv!
“Leveraging Atropisomerism to Obtain a Mutant-Selective c-KIT Inhibitor in Gastrointestinal Stromal Tumors”
A story of privileged heterocycles, atropisomerism and kinase selectivity.
chemrxiv.org/doi/full/10.264…
The R-atropisomer* maintained potency against cellular models of GIST (IC50 < 10 nM) while displaying improved target selectivity, including towards key oncogenic c-KIT mutants. *Cahn-Ingold-Prelog priorities cause the analogs to have opposite stereochemical descriptors.*
Excited to share our new ChemRxiv preprint:
“Leveraging Conformational Control of Neratinib’s C–N Axes to Enhance HER4 Selectivity in Ovarian Cancer”
congrats to the tam @StonyBrookChem and @SDSUChemBiochem
Read here: doi.org/10.26434/chemrxiv.15…
The ‘conformational mapping’ of diarylamine crystal structures suggested that the pan-HER kinase inhibitor neratinib adopts two planar conformations around a C–N axes (similar to cis and trans alkenes). HER family kinases generally preferred the ‘trans’ conformation
The final version of this manuscript is up at @ACSCatalysis
pubs.acs.org/doi/10.1021/acs…
I am sharing this preprint from my group. Inspired by all the great recent skeletal editing work, we developed an atropisomer selective strategy to take Indoles to quinolines. chemrxiv.org/engage/chemr...
Gustafson Group @ Stony Brook retweeted
Our department (@StonyBrookChem) is looking for a PRODiG+ fellow – the appointment is two years, followed by conversion to a tenure-track assistant professor at the conclusion of the fellowship. A unique opportunity!
apply.interfolio.com/178732
Reposting. One more week until the deadline!
The Stony Brook Chemistry Department is searching for a Chemical Biologist at the Associate or Full professor Level. Come join us on Long Island and do some great science! apply.interfolio.com/174211
Gustafson Group @ Stony Brook retweeted
Doctor Gavin Rustin we salute you
Check out our latests work in collaboration with @Taylorlab_Chem ! We evaluated their biomolecular photocaged trifluormethylation reagent on small molecules, finding it effected the rapid trifluoromethylation of diverse aromatics, including several APIs.
chemrxiv.org/engage/chemrxiv…
Check out our latests work in collaboration with @Taylorlab_Chem ! We evaluated their biomolecular photocaged trifluormethylation reagent on small molecules, finding it effected the rapid trifluoromethylation of diverse aromatics, including several APIs.
chemrxiv.org/engage/chemrxiv…
The Stony Brook Chemistry Department is searching for a Chemical Biologist at the Associate or Full professor Level. Come join us on Long Island and do some great science! apply.interfolio.com/174211
Gustafson Group @ Stony Brook retweeted
Professor Jeff Gustafson (Stony Brook University, @GustafsonLab) (gustafsongroup.sdsu.edu/word…) presented the Organic Syntheses Lecture at Notre Dame on September 24th, 2025.












